High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation

BACKGROUND: Lung cancer is one of the most lethal cancers worldwide, but studies have shown that the higher the expression of programmed cell death protein 1 ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), the more likely it will benefit from anti-PD-L1 immunotherapy. The purpose of our stud...

Descripción completa

Detalles Bibliográficos
Autores principales: LIU, LU, XIE, BIN, ZHU, WEI, HE, QIUYAN, ZHOU, JIANHUA, LIU, SHUANG, TAO, YONGGUANG, XIAO, DESHENG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229306/
https://www.ncbi.nlm.nih.gov/pubmed/37305382
http://dx.doi.org/10.32604/or.2023.028227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229306/
https://www.ncbi.nlm.nih.gov/pubmed/37305382
http://dx.doi.org/10.32604/or.2023.028227

Ejemplares similares